PennState/Project/Diauxie/PromoterTest

From 2007.igem.org

(Difference between revisions)
Line 1: Line 1:
'''Promoter Test Constructs'''
'''Promoter Test Constructs'''
-
To test each of the four xyl promoters, each is placed in a construct followed by a ribosome binding site, the reporter green florescent protein, and a terminator. The strength of each is measured by gfp emission.
+
The xyl promoter region promotes in both the direction of genes encoding for both xylA and xylF metabolization and transport proteins. The CPR-cAMP, and xylR binding sites regulate both directions. This means that there are four possibilities for making promoters: xylF facing including the CRP-cAMP binding site, xylF facing without the CRP-cAMP binding site, xylA facing including the CRP-cAMP binding site, and xylF facing without the CRP-cAMP binding site.
 +
 
 +
To test the four xyl promoters, each is placed in a construct followed by a ribosome binding site, the reporter green florescent protein, and a terminator. The strength of each is measured by gfp emission.

Revision as of 23:38, 26 October 2007

Promoter Test Constructs

The xyl promoter region promotes in both the direction of genes encoding for both xylA and xylF metabolization and transport proteins. The CPR-cAMP, and xylR binding sites regulate both directions. This means that there are four possibilities for making promoters: xylF facing including the CRP-cAMP binding site, xylF facing without the CRP-cAMP binding site, xylA facing including the CRP-cAMP binding site, and xylF facing without the CRP-cAMP binding site.

To test the four xyl promoters, each is placed in a construct followed by a ribosome binding site, the reporter green florescent protein, and a terminator. The strength of each is measured by gfp emission.


This construct uses the xylF and xylA facing promoters that includes the CRP-cAMP binding region.


This construct uses the xylF and xylA facing promoters that do not include the CRP-cAMP binding region.


After each of the four promoter constructs are tested individually, the two which include the CRP-cAMP are changed so that a gene expressing the mutant CRP* is included.

This construct uses the xylF and xylA facing promoters that do not include the CRP-cAMP binding region followed by the CRP* gene.